Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD

NCT02937974 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Xuebijing
DRUG: Placebo

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]